share_log

Is There Now An Opportunity In ScanSource, Inc. (NASDAQ:SCSC)?

Is There Now An Opportunity In ScanSource, Inc. (NASDAQ:SCSC)?

现在是否有纳斯达克公司ScanSource, Inc. (NASDAQ:SCSC)的投资机会?
Simply Wall St ·  2024/11/27 23:07

ScanSource, Inc. (NASDAQ:SCSC), is not the largest company out there, but it saw a significant share price rise of 22% in the past couple of months on the NASDAQGS. The recent jump in the share price has meant that the company is trading at close to its 52-week high. As a small cap stock, which tends to lack high analyst coverage, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Today we will analyse the most recent data on ScanSource's outlook and valuation to see if the opportunity still exists.

Scansource公司(纳斯达克股票代码:SCSC)虽然不是最大的公司,但在过去几个月的时间里,在纳斯达克股票市场上看到了显著的股价上涨,上涨了22%。 最近股价的大幅上涨意味着公司的股价接近52周内的高点。 作为一只小盘股,往往缺乏高度的分析师关注,这通常会导致定价存在更多的机会,因为活跃度不够去推动股价更接近公允价值。这里是否仍然存在买入机会?今天我们将分析Scansource最新的前景和估值数据,看看这个机会是否仍然存在。

What's The Opportunity In ScanSource?

在Scansource股票中有哪些机会?

According to our valuation model, ScanSource seems to be fairly priced at around 16.18% above our intrinsic value, which means if you buy ScanSource today, you'd be paying a relatively fair price for it. And if you believe the company's true value is $44.65, there's only an insignificant downside when the price falls to its real value. Is there another opportunity to buy low in the future? Since ScanSource's share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

根据我们的估值模型,Scansource看起来定价合理,大约高出我们的内在价值16.18%,这意味着如果您今天购买Scansource,您将以相对合理的价格购买。 如果您认为公司的真实价值是44.65美元,那么当价格跌至真实价值时,就只会有微不足道的下跌。 未来还有另一个低买入的机会吗?由于Scansource的股价相当波动,我们可能会在未来看到股价进一步下跌(或上升更高),从而给我们另一个购买机会。 这是基于其高`beta`值,这是一个很好的指标,用于衡量股票相对于市场其他部分的移动程度。

Can we expect growth from ScanSource?

我们可以期待Scansource的增长吗?

big
NasdaqGS:SCSC Earnings and Revenue Growth November 27th 2024
纳斯达克股市:SCSC的盈利和营业收入增长情况在2024年11月27日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of ScanSource, it is expected to deliver a negative earnings growth of -1.3%, which doesn't help build up its investment thesis. It appears that risk of future uncertainty is high, at least in the near term.

寻求投资组合增长的投资者可能会考虑在购买公司股票之前考虑该公司的前景。 尽管价值投资者可能会认为相对于价格的内在价值最重要,但更具有说服力的投资理论可能是以较低的价格获得高增长潜力。 尽管在Scansource的情况下,预计其盈利增长率为-1.3%,这无助于构建其投资理论。 看起来未来的不确定性风险至少在短期内是高的。

What This Means For You

这对你意味着什么

Are you a shareholder? SCSC seems fairly priced right now, but given the uncertainty from negative returns in the future, this could be the right time to reduce the risk in your portfolio. Is your current exposure to the stock beneficial for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on the stock, take a look at whether its fundamentals have changed.

您是股东吗?SCSC现在似乎价格相当合理,但鉴于未来负收益的不确定性,这可能是减少投资组合风险的正确时机。您当前持有该股票对您的整体投资组合有益吗?持有前景不佳的股票的机会成本是否太高?在您做出股票决策之前,请查看其基本面是否发生了变化。

Are you a potential investor? If you've been keeping an eye on SCSC for a while, now may not be the most advantageous time to buy, given it is trading around its fair value. The price seems to be trading at fair value, which means there's less benefit from mispricing. In addition to this, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven't considered today, which can help gel your views on SCSC should the price fluctuate below its true value.

您是潜在投资者吗?如果您一直在关注SCSC一段时间,现在可能不是最有利的买入时机,因为其股价已接近公允价值。价格似乎处于公允价值,这意味着定价错误带来的利益较少。此外,负增长前景增加了持有该股票的风险。然而,今天我们还未考虑其他重要因素,这些因素可以在价格波动低于其真实价值时帮助您形成对SCSC的观点。

With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. In terms of investment risks, we've identified 1 warning sign with ScanSource, and understanding it should be part of your investment process.

在这种情况下,除非我们对风险有透彻的了解,否则我们不会考虑投资股票。在投资风险方面,我们已确定与scansource有1个警告信号,了解这一信号应该是您投资过程的一部分。

If you are no longer interested in ScanSource, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您对scansource不再感兴趣,您可以使用我们的免费平台查看超过50只其他具有高增长潜力的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发